Ozempic patient assistance program: A complete guide to getting help
Paying for Ozempic can feel overwhelming, but what if there were a way to get it for free? The Novo Nordisk Patient Assistance Program is designed to help eligible patients access this life-changing medication without the financial burden. Curious if you qualify? Let’s break down everything you need to know to get started.
Key highlights
- Without insurance, Ozempic can cost more than $1,000 each month, which can be unaffordable for many.
- The Ozempic Savings Card can reduce the cost to just $25 a month if you have private or commercial insurance that covers Ozempic.
- The Novo Nordisk Patient Assistance Program (PAP) provides free Ozempic to low-income individuals who meet certain income and insurance requirements.
- Common reasons for denial include income limits, missing documents, or insurance status.
- Nonprofit and state-based programs like Patient Advocate Foundation and RxAssist may be able to offer further assistance if needed.
Ozempic (semaglutide) is an FDA-approved glucagon-like peptide-1 receptor agonist (GLP-1) receptor agonist made by Novo Nordisk. It is used to lower blood sugar in people with type 2 diabetes and is also used off-label for weight loss in people with obesity and overweight. It is also approved to reduce the risk of major adverse cardiovascular events in adults with cardiovascular disease.
Ozempic is in high demand, largely due to its effectiveness in diabetes and weight loss. However, it comes with a high cost, often exceeding $1,000 without insurance. That adds up to around $12,000 annually, making it unaffordable for many patients.
The Novo Nordisk Patient Assistance Program (PAP) is an essential support option for individuals prescribed Ozempic who cannot afford it. This program is specifically designed to help eligible patients access their medication at no cost.
Need help affording Ozempic? Learn about the Novo Nordisk Patient Assistance Program (PAP). Discover eligibility requirements, how to apply, and other ways to save on your prescription costs.
Understanding the Novo Nordisk Patient Assistance Program (PAP): Free Ozempic
Drug manufacturers offer patient assistance programs to help low-income, uninsured patients and underinsured individuals access their medication for free.
The NovoCare Patient Assistance Program (PAP) helps low-income individuals who are uninsured or underinsured and cannot afford their medications. If you qualify, the program will provide you with free Ozempic.
Patients who qualify for the Novo Nordisk PAP can receive Ozempic at no cost. This makes the program especially valuable for those managing type 2 diabetes who may face high out-of-pocket costs. The Novo Nordisk Patient Assistance Program is not only a lifeline for those who need help affording their medications, but it’s also completely free to use.
To apply, you need to meet certain income and eligibility requirements:
You are a U.S. citizen or resident
Your total household income is at or below 400% of the federal poverty level (FPL)
You have a prescription that meets the FDA-approved labeling (e.g. type 2 diabetes)
You are uninsured or have Medicare with no other prescription drug coverage
You do not have private or commercial insurance
You are not enrolled or qualify for any federal, state, or government programs that provide prescription benefits, such as Medicaid, Low Income Subsidy (LIS), or Veterans Affairs (VA) benefits.
You can visit the NovoCare website to check if you qualify and start the application process, or call 1-866-310-7549.
If you’re eligible, there may be income limits, so having documents like recent pay stubs or tax returns ready can help speed up the process. Also, keep in mind that Patient Assistance Programs usually only cover the medication when it’s prescribed for its approved use, so using it for weight loss without type 2 diabetes may not qualify.
Eligibility requirements for the Ozempic PAP
To get Ozempic for free through the Novo Nordisk PAP, you must meet the following criteria:
US residency
You must be a U.S. citizen or legal resident living in the United States.
Income limitations
You must have a total household income at or below 400% of the Federal Poverty Level (FPL). This is the same income threshold used for many assistance programs.
Use the Federal Poverty Level Calculator to calculate your household’s FPL percentage based on your income and household size.
If your household income is at or below 400% FPL, you may be eligible for the Novo Nordisk PAP. For the most up-to-date information, visit the Novo Nordisk PAP website or contact their support.
Insurance status
Uninsured: Patients with no health insurance are eligible to apply.
Medicare: Patients on Medicare may be eligible if:
They have spent more than $1,000 on prescription medications under Medicare Part D this calendar year, or
They were denied Medicare Extra Help/Low Income Subsidy (LIS) and do not have Medicare Part D coverage.
Medicaid: People who are eligible for Medicaid must have applied for and been denied for consideration for the PAP.
No other government programs: In general, applicants cannot be enrolled in or eligible for other federal or state programs, such as:
Medicaid (unless denied),
Low Income Subsidy (LIS)/Extra Help,
Veterans Affairs (VA) benefits, or other government-funded programs.
Meeting these insurance requirements is essential for eligibility for the Novo Nordisk PAP. If you’re not sure about your insurance status or eligibility, help is available through the program’s support line or your healthcare provider.
Prescription requirement
To be eligible for the Novo Nordisk PAP, you must have a valid prescription from a U.S.-licensed healthcare provider for Ozempic.
This prescription must be for a medical use, such as type 2 diabetes, and must be included with your application. Without a current, valid prescription, your application cannot be processed.
Medical necessity
Ozempic must be medically necessary for the treatment of type 2 diabetes by a U.S.-licensed healthcare provider to be eligible for the Novo Nordisk PAP.
It’s important to note that eligibility may not apply if Ozempic is prescribed off-label for weight loss or other non-approved uses. The program is specifically intended to support patients using the medication as indicated by the FDA for managing type 2 diabetes.
Application process: Step-by-step guide
Here’s the process that enrollees can follow:
Step 1: Obtain the application
To begin the process, you’ll need to get the official PAP application form. There are several ways to do this:
Download online: Visit the Novo Nordisk Patient Assistance Program page or go to NovoCare.com to download the application form directly.
Ask your healthcare provider: Your doctor’s office may have copies of the form or can help you complete and submit it.
Call to request by mail: You can call the Novo Nordisk Patient Assistance Program helpline at 1-866-310-7549 to request that a paper application be mailed to you.
Once you’ve obtained the form, you can move on to the next steps, including completing your section, having your healthcare provider fill out their portion, and gathering any required documentation.
Step 2: Gather the required information and documents
To apply for the Ozempic Patient Assistance Program, you’ll need to gather and submit the following:
Patient information: This includes information such as your full legal name, date of birth, current address, contact details, and Social Security Number.
Household information: Applicants must report household information, specifically the number of people in their household and their total annual gross household income.
Proof of income: Applicants are also required to submit proof of income. Acceptable documentation may include recent pay stubs, last year’s federal tax return, Social Security income statements, W-2 or 1099 forms, and unemployment benefit statements. It’s important to note that Novo Nordisk may be able to verify income electronically, but submitting this documentation up front can help avoid delays.
Healthcare provider information: The application must also include detailed healthcare provider information, including the prescribing doctor’s full name, office address, phone number, email address, and valid state medical license information.
Insurance information: If the applicant has any existing insurance coverage, this must be disclosed as well, including private insurance, Medicare, or Medicaid. For those on Medicare, documentation showing over $1,000 in out-of-pocket Part D expenses or a denial letter for Extra Help (LIS) may be required. Medicaid-eligible applicants must include a denial letter from the program.
Patient consent and signature: The patient (or their legal representative) must sign and date the application, providing consent for Novo Nordisk to review and verify the provided information.
Prescriber section: The prescriber section must be fully completed and signed by the healthcare provider. This section includes confirmation of medical necessity and specific prescription details for Ozempic. Both patient and provider signatures are necessary for the application to be processed.
Step 3: Submitting the application
Once you’ve completed the application and gathered all required documentation, the next step is to submit it to Novo Nordisk for review. There are a few methods available, and choosing the right one can help avoid delays.
Online application: If the online portal is available through NovoCare.com, patients or healthcare providers can upload completed forms and documentation directly. The system may require patient identity verification, provider information confirmation, and electronic consent and signatures. This method offers a faster, more streamlined process and confirms once your submission is received.
Paper application: If you’re using the paper version of the application, ensure all sections are completed, including both the patient and prescriber sections. Attach required documentation, such as proof of income and insurance details. Double-check signatures; incomplete forms will delay processing.
Submit via fax/online: Applying promptly and through the preferred channels (fax or online) ensures a smoother and quicker review process. Once submitted, you can typically expect a response within 7–10 business days, depending on volume and completeness of the application.
Step 4: Application review and decision
Once you’ve submitted your completed application and all required documents, Novo Nordisk will review your application within 10 business days. During this time, they will verify your income, insurance, prescription, and medical necessity for Ozempic.
You and your healthcare provider will be notified by mail of the approval or denial, and in some cases by phone or email if contact information is provided. Make sure all information on the application is accurate and complete to avoid delays.
If you haven’t heard back within a week, it’s recommended to follow up. You can check the status of your application by calling the toll-free number 1-866-310-7549. Calling after a week gives enough time for the application to be received and entered into their system.
Step 5: Receiving medication
If approved, the Ozempic will be shipped to your healthcare provider’s office, not your home. You’ll need to coordinate with your provider to pick up the medication from their office. Home delivery is not offered through the Novo Nordisk Patient Assistance Program.
For patients on Medicare Part D, approval is usually granted through the end of the calendar year. If continued assistance is needed beyond that, you’ll need to reapply annually and provide updated documentation to confirm ongoing eligibility.
To avoid a gap in medication, make sure to track your enrollment period and start the renewal process well before the current coverage expires.
Step 6: Re-enrollment
If you wish to continue receiving Ozempic through the Novo Nordisk Patient Assistance Program beyond your current approval period, you must re-enroll annually.
Re-enrollment requires you to:
Complete a new application each year.
Resubmit proof of income and any updated insurance information.
Ensure your healthcare provider fills out and signs the prescriber section again.
Reconfirm medical necessity and prescription details for Ozempic.
It’s strongly recommended to start the re-enrollment process at least 30–60 days before your current coverage ends to avoid any interruption in access to your medication. Being proactive with renewal ensures a smoother transition and uninterrupted treatment.
Common rejection reasons and how to appeal
If your application to the Novo Nordisk Patient Assistance Program is denied, don’t lose hope; there are ways to address common issues and improve your chances on appeal:
Income slightly over limit: If your household income is just above the eligibility threshold, ask your healthcare provider to write a detailed appeal letter explaining your financial situation and medical need. Sometimes, exceptions can be made based on special circumstances.
Missing or incomplete documents: Denials often happen when required paperwork isn’t included or is incomplete. Review the rejection notice carefully and resubmit your application with all missing documents, such as recent W-2 forms, pay stubs, or bank statements to verify income.
Medicare patients: If you’re on Medicare and were denied due to insurance status, consider alternative support programs such as the Extra Help/Low Income Subsidy (LIS) or other nonprofit assistance organizations. Your healthcare provider or a patient advocate can help guide you toward these options.
Appealing promptly and thoroughly can increase your chances of approval. If you need help, don’t hesitate to contact the Novo Nordisk PAP helpline or seek support from your healthcare provider.
Other ways to save on Ozempic
Novo Nordisk also offers savings programs for U.S. citizens and residents with commercial or private insurance coverage. Those enrolled in government-sponsored insurance, such as Medicare or Medicaid, are not eligible.
Ozempic Savings Card
If you have commercial insurance coverage that has coverage for Ozempic, you could pay as little as $25 for a 1-month, 2-month prescription, or 3-month supply with the Ozempic Savings Card, with the following maximum savings:
$100 for a one-month supply
$200 for a two-month supply
$300 for a three-month supply
People with government insurance like Medicaid, Medicare, VA, TRICARE, or similar plans can’t use the Ozempic Savings Card. If you have employer insurance but it doesn’t cover Ozempic, you also can’t use the card. It’s only for people with private or commercial insurance that covers Ozempic.
To apply for the Ozempic Savings Card and check if you qualify, visit the Novo Nordisk website. If you already paid for your Ozempic before you found out about the coupon, you might be able to get some of your money back using Novo Nordisk’s Savings Offer reimbursement form, if you qualify.
Ozempic alternatives
Ozempic can be costly, but there are cheaper alternatives, including GLP-1 and non-GLP-1 medications. If your insurance doesn’t cover it or you’re paying out of pocket, talk to your doctor about alternatives to Ozempic.
GLP-1 alternatives
Mounjaro and Zepbound (tirzepatide)
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Both are once-weekly injections with the same dosages, but they are approved for different indications.
Like Wegovy, Zepbound is FDA-approved for weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) and related health issues like high blood pressure or diabetes. Mounjaro is FDA-approved for controlling blood sugar in adults with type 2 diabetes, like Ozempic and Rybelsus.
Rybelsus
Rybelsus is an oral tablet that is FDA-approved for lowering blood sugar levels in adults with type 2 diabetes and may also help with weight loss. Although it’s not FDA-approved to reduce the risk of heart attack or stroke, studies suggest it’s safe for people with heart disease.
Without insurance, a 30-day supply of Rybelsus costs about $997.58. If you’re eligible, you could pay $10 for Rybelsus (1-month supply) with a copay savings card from the manufacturer. The Rybelsus Savings Card program is limited to those with commercial insurance.
Rybelsus is also available through the Novo Nordisk Patient Assistance Program.
Trulicity
Trulicity (dulaglutide) is a once-weekly subcutaneous injectable GLP-1 agonist that helps control blood sugar levels and reduce cardiovascular risk in adults and children from 10 years of age with type 2 diabetes. Some people may also experience weight loss with it.
Without insurance, a month’s supply is around $800-$900, but with insurance, it can be much lower, depending on your plan.
The Trulicity Savings Card program can reduce the cost of Trulicity to as low as $25 per month if you have commercial insurance that covers Trulicity.
Saxenda and Victoza (liraglutide)
Liraglutide, sold under the brand names Victoza and Saxenda, treats type 2 diabetes and obesity.
Approved in 2010, Saxenda (liraglutide) was the first GLP-1 medication approved for weight loss in adults with obesity or overweight with at least one weight-related health issue. It is also approved for children aged 12 and older with obesity. It’s made by the same company as Wegovy, Novo Nordisk.
Saxenda has the same list price as Wegovy, costing about $1,349.02 without insurance. However, the Saxenda Savings Card offered by Novo Nordisk can bring the cost down to as low as $25 for those with commercial insurance.
Victoza (liraglutide) is another injectable GLP-1 agonist that lowers blood sugar in adults with type 2 diabetes with known heart disease, but it needs to be injected once a day instead of once a week because it doesn’t stay in the body as long as Mounjaro and other alternatives. The FDA approved Liraglutide, the first generic of a once-daily GLP-1 injection, in December 2024.
Unlike Mounjaro, Victoza has proven heart protection benefits. It’s approved for people aged 10 and older. However, Victoza has fewer side effects compared to Mounjaro.
If you don’t have insurance or have limited coverage and have type 2 diabetes, you might be able to get Victoza for free through the Novo Nordisk patient assistance program if you meet certain income and insurance criteria.
Compounded semaglutide
Compounded semaglutide is custom-made by licensed compounding pharmacies to accommodate a patient’s specific needs when commercially available drugs aren’t an option.
Compounding pharmacies offer customized semaglutide, but it’s important to make sure they are licensed and use FDA-approved ingredients. The FDA warns against buying compounded semaglutide with salt forms.
Always consult a healthcare professional for medical advice before buying medication. Be careful when buying semaglutide online, as some products may not have the FDA-approved ingredient, which can be risky for your health.
You might choose compounded semaglutide instead of the brand version for various reasons, like supply issues, individual needs such as custom dosing, allergies, or additional ingredients to reduce side effects and improve effectiveness.
Compounded tirzepatide
Compounded tirzepatide is a customized version of the medication, typically made at specialty pharmacies but not reviewed or approved by the FDA. It is available to patients that require a custom dosing or formulation that is not commercially available.
The cost of compounded tirzepatide without insurance can range from about $300 to $500 per month. However, prices vary depending on the compounding pharmacy you use, dosage, and quantity.
Non-GLP-1 alternatives
Metformin: Metformin (Glumetza and Fortamet) is a pill used to treat type 2 diabetes by helping control blood sugar levels. On average, metformin costs $35 per month without insurance.
Phentermine/topiramate (Qsymia): Topiramate is a once-daily medication used to treat seizures and prevent migraines. Phentermine is an appetite suppressant that works by increasing levels of norepinephrine in the brain, which signals a decrease in hunger. It can also be used for weight loss in combination with other drugs. On average, Qsymia costs $149 per month without insurance.
Naltrexone/bupropion (Contrave): It is taken twice daily and used to help with weight loss by reducing hunger and cravings. It combines two drugs, naltrexone and bupropion, to affect brain chemicals that control hunger. On average, Contrave costs $694–817 per month without insurance.
Orlistat (Xenical or Alli): It is taken three times daily and helps with weight loss by blocking the absorption of some fat from the food you eat. It works in the stomach and intestines to reduce the number of calories your body absorbs. On average, Xenical costs $709 per month without insurance.
Flexible Spending Accounts (FSAs) and Health Savings Accounts (HSAs)
If you have a health savings account (HSA) or flexible savings account (FSA), you can use that money to pay for your Ozempic medication. It won’t lower the price at the pharmacy, but it can save you money over time because you’re using pre-tax dollars.
Prescription discount cards
Pharmacy discount programs like GoodRx and SingleCare can help lower the cost of medications, including Ozempic, if you’re paying out of pocket.
GoodRx provides discount coupons that can be used at most major pharmacies, including Walgreens, CVS, and Walmart. For example, a 30-day supply of Ozempic might cost around $1,000 without insurance, but when using a GoodRx coupon, the price could drop to about $965 at participating pharmacies.
SingleCare also offers discount cards that can be used at many pharmacies. You can get Ozempic for as low as $822 per month when using a SingleCare discount card.
RxSaver offers prescription discount cards that can help you save up to 80% on medications, including Ozempic, at participating pharmacies like CVS, Walgreens, and Walmart. You can access these discounts instantly through their website or mobile app, with no membership or sign-up required.
Checking online pharmacies
Buying Ozempic online can be safe if you use trusted sources. The FDA strongly recommends purchasing prescription medications with a prescription from a licensed doctor and licensed pharmacies. Before the medication shipment, using the National Association of Boards of Pharmacy’s search tool, you can verify if an online pharmacy is legitimate.
Nonprofit and state-based assistance programs
If you’re unable to qualify for the Novo Nordisk Patient Assistance Program, several nonprofit and state-based resources may help. These programs can serve as valuable alternatives or supplements if you’re facing high medication costs or if your PAP application is denied.
Patient Advocate Foundation (PAF)
Patient Advocate Foundation offers financial assistance and grants to patients with chronic illnesses, including support for medication costs related to diabetes and other long-term conditions.
RxAssist
A comprehensive database of patient assistance programs and drug discount options, helping you find savings on prescriptions like Ozempic.
Medicare
Medicare Part D drug plans and Medicare Advantage Prescription Drug Plans (MA-PD) do not cover weight loss drugs. If Ozempic was prescribed for type 2 diabetes or reducing certain risks in people with type 2 diabetes and heart disease, it would most likely be covered. If you have Medicare Part D or a Medicare Advantage plan, Ozempic may be covered for treating type 2 diabetes, depending on your plan. You can check your plan’s formulary to see if it’s covered.
To see how much you’ll pay for Ozempic, check your plan’s drug list, called a drug formulary. It shows which medicines are covered and associated copays, based on the drug tier. Coverage varies by plan and medical necessity. The price will depend on your plan’s copay and whether you’ve met your deductible.
Currently, no Medicare plans, including original Medicare or Medicare Advantage, can cover medication prescribed for weight loss due to a legal prohibition. A bill in the U.S. Congress could change this in the future, and some organizations are working to get it passed.
Medicaid
Medicaid coverage can vary by state. Each state decides which drugs are covered by Medicaid. To see if Ozempic is covered in your area, check your health insurance plan’s list of covered drugs or contact your state Medicaid agency. You must also meet the income requirements set by your state to qualify for coverage.
Medicaid usually doesn’t cover Ozempic if it’s used for something it’s not officially FDA-approved for, like weight loss. To find out if your Medicaid plan covers Ozempic, contact your state Medicaid agency.
Tips and considerations
Start the application process early: Don’t wait until the last minute to apply or reapply; processing takes time, and delays could interrupt access to your medication.
Ensure all information is accurate and complete: Incomplete or incorrect applications will be returned, which can significantly delay your approval.
Maintain communication with your healthcare provider: Your healthcare provider plays a key role in the application process and can help ensure all required documentation is submitted correctly.
Understand renewal requirements: If approved, know when your benefits expire and how to reapply to avoid any gaps in coverage.
Report any changes in insurance or income: Eligibility is based on current circumstances, so be sure to update the program with any changes that could affect your status.
Be patient: The process can take time, so plan and stay informed while your application is under review.
FAQs
Does Medicare cover Ozempic?
Yes, Medicare typically covers Ozempic under Part D (prescription drug coverage) when it is prescribed for the treatment of type 2 diabetes. However, Medicare does not cover Ozempic if it is prescribed solely for weight loss, as weight loss drugs are generally excluded from coverage.
Can I use the savings card with insurance?
Yes, you can use the Ozempic savings card if you have private or commercial insurance. However, the savings card cannot be used with government-funded insurance plans like Medicare or Medicaid.
What if I’m denied?
If you’re denied assistance through the Novo Nordisk PAP, you can explore help from nonprofit organizations that offer prescription support.
Conclusion
There are multiple assistance programs available, so don’t assume you won’t qualify; help is within reach.
The Novo Nordisk Patient Assistance Program is a vital resource for eligible U.S. patients struggling to afford Ozempic.
If you meet the eligibility criteria, explore this option and work closely with your healthcare provider throughout the application process.
If you’re struggling to afford Ozempic, the Novo Nordisk PAP offers a straightforward way to get financial help. Take the first step and apply today.
Remember, affordable access to the medications you need is possible. The PAP offers a key pathway to help make that a reality for those who qualify.
